The relation between Helicobacter pylori and nonsteroidal anti- inflammatory drugs

American Journal of Medicine

Volumn 105, Issue 5 A, 1998, Pages 22S-27S

  Barkin, Jamie ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; BISMUTH CITRATE; GASTROINTESTINAL AGENT; METRONIDAZOLE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROSTAGLANDIN; TETRACYCLINE;

CLINICAL TRIAL; CONFERENCE PAPER; DISEASE PREDISPOSITION; DRUG INDUCED DISEASE; GASTRITIS; GASTROINTESTINAL MUCOSA; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; PRIORITY JOURNAL; ULCEROGENESIS;

EID: 0032476567     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(98)00277-0     Document Type: Conference Paper

References (51)

1. Fries J.F., Miller S.R., Spitz P.W., et al. Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use. Gastroenterology. 96:(suppl):1989;647-655.
2. Henry D., Dobson A., Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology. 105:1993;1078-1088.
3. Dooley C.P., Cohen H., Fitzgibbons P.L., et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med. 321:1989;1562-1566.
4. Henry D., Lim L.L.-Y., García Rodríguez L.A., et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs results of a collaborative meta-analysis . BMJ. 312:1996;1563-1566.
5. Mitchell J.A., Akarasereenont P., Thiemermann C., et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA. 90:1993;11693-11697.
6. Taha A.S., Angerson W., Nakshabendi I., et al. Gastric and duodenal mucosal blood flow in patients receiving non-steroidal anti-inflammatory drugs influence of age, smoking, ulceration and Helicobacter pylori. Aliment Pharmacol Ther. 7:1993;41-45.
7. Figura N. Identifiable Helicobacter pylori strains or factors important in the development of duodenal ulcer disease. Helicobacter. 2:(suppl 1):1997;S3-S12.
8. Mobley H.L. Helicobacter pylori factors associated with disease development. Gastroenterology. 113:(suppl 6):1997;S21-S28.
9. Cutler A.F., Havstad S., Ma C.K., et al. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology. 109:1995;136-141.
10. Cutler A., Schubert A., Schubert T. Role of Helicobacter pylori serology in evaluating treatment success. Dig Dis Sci. 38:1993;2262-2266.
11. Perez-Perez G.I., Cutler A.F., Blaser M.J. Value of serology as a noninvasive method for evaluating the efficacy of treatment of Helicobacter pylori infection. Clin Infect Dis. 25:1997;1038-1043.
12. Taha A.S., Boothman P., Nakshabendi I., et al. Diagnostic tests for Helicobacter pylori comparison and influence of non-steroidal anti-inflammatory drugs . J Clin Pathol. 45:1992;709-712.
13. Taha A.S., Reid J., Boothman P., et al. Serological diagnosis of Helicobacter pylori - evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs. Gut. 34:1993;461-465.
14. Hawkey G.M., Everitt S., Pearson G.M., et al. Non-steroidal anti-inflammatory drugs and Helicobacter pylori as independent risk factors for peptic ulcer bleeding. (Abstr.) Gastroenterology. 112:(suppl):1997;A144.
15. Westblom T.U., Phadnis S., Yang P., Czinn S.J. Diagnosis of Helicobacter pylori infection by means of a polymerase chain reaction assay for gastric juice aspirates. Clin Infect Dis. 16:1993;367-371.
16. Westblom T.U. Molecular diagnosis of Helicobacter pylori. Immunol Invest. 26:1997;163-174.
17. Caselli M., Pazzi P., LaCorte R., et al. Campylobacter-like organisms, nonsteroidal anti-inflammatory drugs and gastric lesions in patients with rheumatoid arthritis. Digestion. 44:1989;101-104.
18. Shallcross T.M., Rathbone B.J., Wyatt J.I., Heatley R.V. Helicobacter pylori associated chronic gastritis and peptic ulceration in patients taking non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 4:1990;515-522.
19. Graham D.Y., Lidsky M.D., Cox A.M., et al. Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection. Gastroenterology. 100:1991;1653-1657.
20. Loeb D.S., Talley N.J., Ahlquist D.A., et al. Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury the role of Helicobacter pylori . Gastroenterology. 102:1992;1899-1905.
21. Santucci L., Fiorucci S., Patoia L., et al. Severe gastric mucosal damage induced by NSAIDs in healthy subjects is associated with Helicobacter pylori infection and high levels of serum pepsinogens. Dig Dis Sci. 40:1995;2074-2080.
22. Taha A.S., Nakshabendi I., Lee F.D., et al. Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs comparison and correlation with peptic ulceration . J Clin Pathol. 45:1992;135-139.
23. Laine L., Marin-Sorensen M., Weinstein W.M. Nonsteroidal antiinflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development. Am J Gastroenterol. 87:1992;1398-1402.
24. Quinn C.M., Bjarnason I., Price A.B. Gastritis in patients on non-steroidal anti-inflammatory drugs. Histopathology. 23:1993;341-348.
25. McCarthy C.J., McDermott M., Hourihane D., O'Morain C. Chemical gastritis induced by naproxen in the absence of Helicobacter pylori infection. J Clin Pathol. 48:1995;61-63.
26. Laine L., Cominelli F., Sloane R., et al. Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production a controlled double-blind trial . Aliment Pharmacol Ther. 9:1995;127-135.
27. Lanza F.L., Evans D.G., Graham D.Y. Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers. Am J Gastroenterol. 86:1991;735-737.
28. Goggin P.M., Collins D.A., Jazrawi R.P., et al. Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis. Gut. 34:1993;1677-1680.
29. Thillainayagam A.V., Tabaqchali S., Warrington S.J., Farthing M.J. Interrelationships between Helicobacter pylori infection, nonsteroidal antiinflammatory drugs and gastroduodenal disease a prospective study in healthy volunteers . Dig Dis Sci. 39:1994;1085-1089.
30. Lipscomb G.R., Wallis N., Armstrong G., et al. Influence of Helicobacter pylori on gastric mucosal adaptation to naproxen in man. Dig Dis Sci. 41:1996;1583-1588.
31. Hawkey C.J., Karrasch J.A., Szczepanski L., et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med. 338:1998;727-734.
32. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med. 338:1998;719-726.
33. Hudson N., Balsitis M., Filipowicz F., Hawkey C.J. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut. 34:1993;748-751.
34. Heresbach D., Raoul J.L., Bretagne J.F., et al. Helicobacter pylori a risk and severity factor of non-steroidal anti-inflammatory drug induced gastropathy . Gut. 33:1992;1608-1611.
35. Kim J.G., Graham D.Y. Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy. Am J Gastroenterol. 89:1994;203-207.
36. Li E.K.M., Sung J.J.Y., Suen R., et al. Helicobacter pylori infection increases the risk of peptic ulcers in chronic users of non-steroidal anti-inflammatory drugs. Scand J Rheumatol. 25:1996;42-46.
37. Pilotto A., Franceschi M., Leandro G., et al. The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly. Eur J Gastroenterol Hepatol. 9:1997;951-956.
38. Greenberg P.D., Albert C.M., Ridker P.M., et al. Helicobacter pylori as a risk factor for peptic ulcers in patients taking low-dose aspirin. (Abstr.) Gastroenterology. 112:(suppl):1997;A133.
39. Chan F.K., Sung J.J., Chung S.C., et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet. 350:1997;975-979.
40. Mertz-Nielsen A., Steenberg P., Neumark T., et al. Colloidal bismuth subcitrate causes sustained release of gastric mucosal prostaglandin E2. Aliment Pharmacol Ther. 5:1991;127-133.
41. Pilotto A., Leandro G., Di Mario F., et al. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly a case control study . Dig Dis Sci. 42:1997;586-591.
42. Labenz J., Tillenburg B., Stolte M., et al. Ulcer healing by eradicating Helicobacter pylori. (Abstr.) Gastroenterology. 108:(suppl):1995;A140.
43. Al-Assi M.T., Genta R.M., Karttunen T.J., Graham D.Y. Ulcer site and complications relation to Helicobacter pylori infection and NSAID use . Endoscopy. 28:1996;229-233.
44. Silverstein F.E., Graham D.Y., Senior J.R., et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 123:1995;241-249.
45. Simon L.S., Hatoum H.T., Bittman R.M., et al. Risk factors for serious nonsteroidal-induced gastrointestinal complications regression analysis of the MUCOSA trial . Fam Med. 28:1996;204-210.
46. Aalykke C., Lauritsen J.M., Hallas J., et al. Helicobacter pylori - a risk factor in NSAID-related bleeding peptic ulcer a prospective case control study . (Abstr.) Gastroenterology. 112:(suppl):1997;A51.
47. Taha A.S., McLaughlin S., Holland P.J., et al. Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis. Ann Rheum Dis. 49:1990;354-358.
48. Laine L., Sloane R., Ferretti M., Cominelli F. A randomized, double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production. Gastrointest Endosc. 42:1995;428-433.
49. Bianchi Porro G., Parente F., Imbesi V., et al. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users response to omeprazole dual therapy . Gut. 39:1996;22-26.
50. Berkelhammer C. Helicobacter pylori and ulcer in patients taking NSAIDs. (Letter) JAMA. 273:1995;376.
51. NIH Consensus Conference: Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA. 272:1994;65-69.